XML 56 R39.htm IDEA: XBRL DOCUMENT
v3.22.4

Fair Value of Assets and Liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Fair Value Disclosures [Abstract] |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | Assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 are summarized below (dollars in millions):
December 31, 2022: |  |  |  | Fair Value Measurements Using:
|  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: (1) |  |  |  |  |  |  |  |
Fixed maturity securities – available-for-sale: |  |  |  |  |  |  |  |
Corporate |  | $ | 33,969 |  |  | $ | — |  |  | $ | 29,670 |  |  | $ | 4,299 |
Canadian government |  | 3,626 |  |  | — |  |  | 3,626 |  |  | — |
RMBS |  | 941 |  |  | — |  |  | 931 |  |  | 10 |
ABS |  | 3,878 |  |  | — |  |  | 2,603 |  |  | 1,275 |
CMBS |  | 1,623 |  |  | — |  |  | 1,555 |  |  | 68 |
U.S. government |  | 1,482 |  |  | 1,388 |  |  | 85 |  |  | 9 |
State and political subdivisions |  | 1,119 |  |  | — |  |  | 1,093 |  |  | 26 |
Other foreign government |  | 6,263 |  |  | — |  |  | 6,228 |  |  | 35 |
Total fixed maturity securities – available-for-sale |  | 52,901 |  |  | 1,388 |  |  | 45,791 |  |  | 5,722 |
Equity securities |  | 134 |  |  | 68 |  |  | — |  |  | 66 |
Funds withheld at interest – embedded derivatives |  | (370) |  |  | — |  |  | — |  |  | (370) |
Funds withheld at interest |  | 54 |  |  | — |  |  | — |  |  | 54 |
Cash equivalents |  | 1,535 |  |  | 1,535 |  |  | — |  |  | — |
Short-term investments |  | 121 |  |  | 54 |  |  | 54 |  |  | 13 |
Other invested assets: |  |  |  |  |  |  |  |
Derivatives |  | 170 |  |  | — |  |  | 170 |  |  | — |
Other |  | 23 |  |  | — |  |  | 23 |  |  | — |
Total other invested assets |  | 193 |  |  | — |  |  | 193 |  |  | — |
Total |  | $ | 54,568 |  |  | $ | 3,045 |  |  | $ | 46,038 |  |  | $ | 5,485 |
Liabilities: |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives |  | $ | 653 |  |  | $ | — |  |  | $ | — |  |  | $ | 653 |
Other liabilities: |  |  |  |  |  |  |  |
Funds withheld at interest – embedded derivatives |  | (361) |  |  | — |  |  | — |  |  | (361) |
Derivatives |  | 183 |  |  | — |  |  | 183 |  |  | — |
Total |  | $ | 475 |  |  | $ | — |  |  | $ | 183 |  |  | $ | 292 |
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of December 31, 2022, the fair value of such investments was $683 million.
December 31, 2021: |  |  |  | Fair Value Measurements Using:
|  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: (1) |  |  |  |  |  |  |  |
Fixed maturity securities – available-for-sale: |  |  |  |  |  |  |  |
Corporate |  | $ | 38,103 |  |  | $ | — |  |  | $ | 34,215 |  |  | $ | 3,888 |
Canadian government |  | 4,944 |  |  | — |  |  | 4,944 |  |  | — |
RMBS |  | 1,050 |  |  | — |  |  | 1,049 |  |  | 1 |
ABS |  | 4,005 |  |  | — |  |  | 2,908 |  |  | 1,097 |
CMBS |  | 1,849 |  |  | — |  |  | 1,768 |  |  | 81 |
U.S. government |  | 2,105 |  |  | 1,993 |  |  | 100 |  |  | 12 |
State and political subdivisions |  | 1,323 |  |  | — |  |  | 1,290 |  |  | 33 |
Other foreign government |  | 7,370 |  |  | — |  |  | 7,337 |  |  | 33 |
Total fixed maturity securities – available-for-sale |  | 60,749 |  |  | 1,993 |  |  | 53,611 |  |  | 5,145 |
Equity securities |  | 151 |  |  | 101 |  |  | — |  |  | 50 |
Funds withheld at interest – embedded derivatives |  | 104 |  |  | — |  |  | — |  |  | 104 |
Funds withheld at interest |  | 83 |  |  | — |  |  | — |  |  | 83 |
Cash equivalents |  | 1,138 |  |  | 1,138 |  |  | — |  |  | — |
Short-term investments |  | 64 |  |  | — |  |  | 36 |  |  | 28 |
Other invested assets: |  |  |  |  |  |  |  |
Derivatives |  | 175 |  |  | — |  |  | 175 |  |  | — |
Other |  | 52 |  |  | — |  |  | 52 |  |  | — |
Total other invested assets |  | 227 |  |  | — |  |  | 227 |  |  | — |
Total |  | $ | 62,516 |  |  | $ | 3,232 |  |  | $ | 53,874 |  |  | $ | 5,410 |
Liabilities: |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives |  | $ | 855 |  |  | $ | — |  |  | $ | — |  |  | $ | 855 |
Other liabilities: |  |  |  |  |  |  |  |
Funds withheld at interest – embedded derivatives |  | (61) |  |  | — |  |  | — |  |  | (61) |
Derivatives |  | 39 |  |  | — |  |  | 39 |  |  | — |
Total |  | $ | 833 |  |  | $ | — |  |  | $ | 39 |  |  | $ | 794 |
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of December 31, 2021, the fair value of such investments was $581 million.
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] | The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of December 31, 2022 and 2021 (dollars in millions):
|  | Estimated Fair Value |  | Valuation |  | Unobservable |  | Range (Weighted Average)
Assets: |  | 2022 |  | 2021 |  | Technique |  | Input |  | 2022 |  | 2021
Corporate |  | $ | 25 |  |  | $ | 49 |  |  | Market comparable securities |  | Liquidity premium |  | 1% |  | 0-1% (1%)
|  |  |  |  |  |  |  | EBITDA Multiple |  | 5.3x |  | 5.2x-7.0x (6.4x)
ABS |  | 274 |  |  | 205 |  |  | Market comparable securities |  | Liquidity premium |  | 0-18% (2%) |  | 2-18% (4%)
U.S. government |  | 9 |  |  | 12 |  |  | Market comparable securities |  | Liquidity premium |  | 0-1% (1%) |  | 0-1% (1%)
Equity securities |  | 9 |  |  | 5 |  |  | Market comparable securities |  | EBITDA Multiple |  | 8.4x-11.2x (9.6x) |  | 6.9x-10.6x (8.0x)
Funds withheld at interest – embedded derivatives |  | (34) |  |  | 182 |  |  | Total return swap |  | Mortality |  | 0-100% (3%) |  | 0-100% (3%)
|  |  |  |  |  |  |  | Lapse |  | 0-35% (17%) |  | 0-35% (18%)
|  |  |  |  |  |  |  | Withdrawal |  | 0-5% (4%) |  | 0-5% (4%)
|  |  |  |  |  |  |  | CVA |  | 0-5% (0%) |  | 0-5% (0%)
|  |  |  |  |  |  |  | Crediting rate |  | 1-4% (2%) |  | 1-4% (2%)
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities – embedded derivatives – indexed annuities |  | 530 |  |  | 693 |  |  | Discounted cash flow |  | Mortality |  | 0-100% (3%) |  | 0-100% (2%)
|  |  |  |  |  |  |  | Lapse |  | 0-35% (16%) |  | 0-35% (16%)
|  |  |  |  |  |  |  | Withdrawal |  | 0-5% (3%) |  | 0-5% (3%)
|  |  |  |  |  |  |  | Option budget projection |  | 1-4% (2%) |  | 1-4% (2%)
Interest-sensitive contract liabilities – embedded derivatives – variable annuities |  | 124 |  |  | 162 |  |  | Discounted cash flow |  | Mortality |  | 0-100% (2%) |  | 0-100% (2%)
|  |  |  |  |  |  |  | Lapse |  | 0-25% (3%) |  | 0-25% (4%)
|  |  |  |  |  |  |  | Withdrawal |  | 0-7% (6%) |  | 0-7% (5%)
|  |  |  |  |  |  |  | CVA |  | 0-5% (1%) |  | 0-5% (1%)
|  |  |  |  |  |  |  | Long-term volatility |  | 0-27% (13%) |  | 0-27% (14%)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] |
For the year ended December 31, 2022: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net(1) |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 3,888 |  |  | $ | 33 |  |  | $ | 1,179 |  |  | $ | 45 |  |  | $ | 50 |  |  | $ | 28 |  |  | $ | 165 |  |  | $ | 83 |  |  | $ | (855) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14) |  |  | — |
Investment related gains (losses), net |  | (8) |  |  | — |  |  | (11) |  |  | (1) |  |  | 6 |  |  | 1 |  |  | (173) |  |  | — |  |  | 38 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 98 |
Included in other comprehensive income (loss) |  | (474) |  |  | (11) |  |  | (194) |  |  | (4) |  |  | — |  |  | (1) |  |  | — |  |  | (8) |  |  | — |
Purchases(2) |  | 1,669 |  |  | — |  |  | 521 |  |  | — |  |  | 14 |  |  | 33 |  |  | — |  |  | 3 |  |  | 1 |
Sales(2) |  | (182) |  |  | — |  |  | (58) |  |  | (6) |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | — |
Settlements(2) |  | (577) |  |  | — |  |  | (140) |  |  | (5) |  |  | — |  |  | (28) |  |  | — |  |  | (10) |  |  | 65 |
Transfers into Level 3 |  | 88 |  |  | 13 |  |  | 130 |  |  | 10 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (111) |  |  | — |  |  | (74) |  |  | (4) |  |  | — |  |  | (20) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 4,299 |  |  | $ | 35 |  |  | $ | 1,353 |  |  | $ | 35 |  |  | $ | 66 |  |  | $ | 13 |  |  | $ | (8) |  |  | $ | 54 |  |  | $ | (653) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 4 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (14) |  |  | $ | — |
Investment related gains (losses), net |  | (18) |  |  | — |  |  | (10) |  |  | — |  |  | 4 |  |  | — |  |  | (173) |  |  | — |  |  | 33 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 33 |
Included in other comprehensive income (loss) |  | (467) |  |  | (11) |  |  | (195) |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | (8) |  |  | — |
(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the year ended December 31, 2021: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net(1) |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 3,029 |  |  | $ | 17 |  |  | $ | 254 |  |  | $ | 23 |  |  | $ | 53 |  |  | $ | 15 |  |  | $ | 58 |  |  | $ | 56 |  |  | $ | (907) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 5 |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | — |
Investment related gains (losses), net |  | (5) |  |  | — |  |  | — |  |  | — |  |  | 13 |  |  | — |  |  | 107 |  |  | — |  |  | (7) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10 |
Included in other comprehensive income (loss) |  | (28) |  |  | (4) |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |
Purchases(2) |  | 1,506 |  |  | 25 |  |  | 1,038 |  |  | — |  |  | 9 |  |  | 31 |  |  | — |  |  | 36 |  |  | (34) |
Sales(2) |  | (53) |  |  | — |  |  | (6) |  |  | — |  |  | (25) |  |  | (3) |  |  | — |  |  | — |  |  | — |
Settlements(2) |  | (587) |  |  | (5) |  |  | (186) |  |  | (3) |  |  | — |  |  | (10) |  |  | — |  |  | (4) |  |  | 83 |
Transfers into Level 3 |  | 29 |  |  | — |  |  | 84 |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (8) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 3,888 |  |  | $ | 33 |  |  | $ | 1,179 |  |  | $ | 45 |  |  | $ | 50 |  |  | $ | 28 |  |  | $ | 165 |  |  | $ | 83 |  |  | $ | (855) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 4 |  |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4) |  |  | $ | — |
Investment related gains (losses), net |  | (7) |  |  | — |  |  | — |  |  | — |  |  | 7 |  |  | — |  |  | 107 |  |  | — |  |  | (15) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (72) |
Included in other comprehensive income (loss) |  | (24) |  |  | (4) |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |
(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the year ended December 31, 2020: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 2,186 |  |  | $ | 720 |  |  | $ | 208 |  |  | $ | 25 |  |  | $ | 77 |  |  | $ | 2 |  |  | $ | 121 |  |  | $ | — |  |  | $ | (930) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | — |
Investment related gains (losses), net |  | (22) |  |  | — |  |  | — |  |  | — |  |  | (13) |  |  | — |  |  | (63) |  |  | — |  |  | 8 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (30) |
Included in other comprehensive income (loss) |  | 28 |  |  | 1 |  |  | (7) |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Purchases(1) |  | 1,193 |  |  | — |  |  | 149 |  |  | — |  |  | 3 |  |  | 17 |  |  | — |  |  | 60 |  |  | (32) |
Sales(1) |  | (182) |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Settlements(1) |  | (229) |  |  | — |  |  | (59) |  |  | (3) |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | 77 |
Transfers into Level 3 |  | 57 |  |  | — |  |  | 38 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (4) |  |  | (704) |  |  | (70) |  |  | — |  |  | (14) |  |  | (1) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 3,029 |  |  | $ | 17 |  |  | $ | 254 |  |  | $ | 23 |  |  | $ | 53 |  |  | $ | 15 |  |  | $ | 58 |  |  | $ | 56 |  |  | $ | (907) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4) |  |  | $ | — |
Investment related gains (losses), net |  | (23) |  |  | — |  |  | — |  |  | — |  |  | (13) |  |  | — |  |  | (63) |  |  | — |  |  | (2) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (107) |
Included in other comprehensive income (loss) |  | (34) |  |  | 1 |  |  | (8) |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
(1)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] |
For the year ended December 31, 2022: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net(1) |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 3,888 |  |  | $ | 33 |  |  | $ | 1,179 |  |  | $ | 45 |  |  | $ | 50 |  |  | $ | 28 |  |  | $ | 165 |  |  | $ | 83 |  |  | $ | (855) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14) |  |  | — |
Investment related gains (losses), net |  | (8) |  |  | — |  |  | (11) |  |  | (1) |  |  | 6 |  |  | 1 |  |  | (173) |  |  | — |  |  | 38 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 98 |
Included in other comprehensive income (loss) |  | (474) |  |  | (11) |  |  | (194) |  |  | (4) |  |  | — |  |  | (1) |  |  | — |  |  | (8) |  |  | — |
Purchases(2) |  | 1,669 |  |  | — |  |  | 521 |  |  | — |  |  | 14 |  |  | 33 |  |  | — |  |  | 3 |  |  | 1 |
Sales(2) |  | (182) |  |  | — |  |  | (58) |  |  | (6) |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | — |
Settlements(2) |  | (577) |  |  | — |  |  | (140) |  |  | (5) |  |  | — |  |  | (28) |  |  | — |  |  | (10) |  |  | 65 |
Transfers into Level 3 |  | 88 |  |  | 13 |  |  | 130 |  |  | 10 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (111) |  |  | — |  |  | (74) |  |  | (4) |  |  | — |  |  | (20) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 4,299 |  |  | $ | 35 |  |  | $ | 1,353 |  |  | $ | 35 |  |  | $ | 66 |  |  | $ | 13 |  |  | $ | (8) |  |  | $ | 54 |  |  | $ | (653) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 4 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (14) |  |  | $ | — |
Investment related gains (losses), net |  | (18) |  |  | — |  |  | (10) |  |  | — |  |  | 4 |  |  | — |  |  | (173) |  |  | — |  |  | 33 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 33 |
Included in other comprehensive income (loss) |  | (467) |  |  | (11) |  |  | (195) |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | (8) |  |  | — |
(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the year ended December 31, 2021: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives, net(1) |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 3,029 |  |  | $ | 17 |  |  | $ | 254 |  |  | $ | 23 |  |  | $ | 53 |  |  | $ | 15 |  |  | $ | 58 |  |  | $ | 56 |  |  | $ | (907) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 5 |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | — |
Investment related gains (losses), net |  | (5) |  |  | — |  |  | — |  |  | — |  |  | 13 |  |  | — |  |  | 107 |  |  | — |  |  | (7) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10 |
Included in other comprehensive income (loss) |  | (28) |  |  | (4) |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |
Purchases(2) |  | 1,506 |  |  | 25 |  |  | 1,038 |  |  | — |  |  | 9 |  |  | 31 |  |  | — |  |  | 36 |  |  | (34) |
Sales(2) |  | (53) |  |  | — |  |  | (6) |  |  | — |  |  | (25) |  |  | (3) |  |  | — |  |  | — |  |  | — |
Settlements(2) |  | (587) |  |  | (5) |  |  | (186) |  |  | (3) |  |  | — |  |  | (10) |  |  | — |  |  | (4) |  |  | 83 |
Transfers into Level 3 |  | 29 |  |  | — |  |  | 84 |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (8) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 3,888 |  |  | $ | 33 |  |  | $ | 1,179 |  |  | $ | 45 |  |  | $ | 50 |  |  | $ | 28 |  |  | $ | 165 |  |  | $ | 83 |  |  | $ | (855) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 4 |  |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4) |  |  | $ | — |
Investment related gains (losses), net |  | (7) |  |  | — |  |  | — |  |  | — |  |  | 7 |  |  | — |  |  | 107 |  |  | — |  |  | (15) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (72) |
Included in other comprehensive income (loss) |  | (24) |  |  | (4) |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |
(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward. (2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the year ended December 31, 2020: |  | Fixed maturity securities – available-for-sale |  |  |  |  |  | Funds withheld at interest –embedded derivatives |  | Funds withheld at interest |  | Interest-sensitive contract liabilities – embedded derivatives
|  | Corporate |  | Foreign govt |  | Structured securities |  | U.S. and local govt |  | Equity securities |  | Short-term investments |  |  |
Fair value, beginning of period |  | $ | 2,186 |  |  | $ | 720 |  |  | $ | 208 |  |  | $ | 25 |  |  | $ | 77 |  |  | $ | 2 |  |  | $ | 121 |  |  | $ | — |  |  | $ | (930) |
Total gains/losses (realized/unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | 2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | — |
Investment related gains (losses), net |  | (22) |  |  | — |  |  | — |  |  | — |  |  | (13) |  |  | — |  |  | (63) |  |  | — |  |  | 8 |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (30) |
Included in other comprehensive income (loss) |  | 28 |  |  | 1 |  |  | (7) |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Purchases(1) |  | 1,193 |  |  | — |  |  | 149 |  |  | — |  |  | 3 |  |  | 17 |  |  | — |  |  | 60 |  |  | (32) |
Sales(1) |  | (182) |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Settlements(1) |  | (229) |  |  | — |  |  | (59) |  |  | (3) |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | 77 |
Transfers into Level 3 |  | 57 |  |  | — |  |  | 38 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of Level 3 |  | (4) |  |  | (704) |  |  | (70) |  |  | — |  |  | (14) |  |  | (1) |  |  | — |  |  | — |  |  | — |
Fair value, end of period |  | $ | 3,029 |  |  | $ | 17 |  |  | $ | 254 |  |  | $ | 23 |  |  | $ | 53 |  |  | $ | 15 |  |  | $ | 58 |  |  | $ | 56 |  |  | $ | (907) |
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4) |  |  | $ | — |
Investment related gains (losses), net |  | (23) |  |  | — |  |  | — |  |  | — |  |  | (13) |  |  | — |  |  | (63) |  |  | — |  |  | (2) |
Interest credited |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (107) |
Included in other comprehensive income (loss) |  | (34) |  |  | 1 |  |  | (8) |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
(1)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Fair Value Assets Measured On Nonrecurring Basis [Text Block] | Nonrecurring Fair Value Measurements The Company has certain assets subject to measurement at fair value on a nonrecurring basis, in periods subsequent to their initial recognition if they are determined to be impaired. For the years ended December 31, 2022 and 2021, the Company did not have any material assets that were measured at fair value due to impairment.
Financial Instruments Carrying Amounts And Estimated Fair Value [Table Text Block] | The following table presents the carrying values and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of December 31, 2022 and 2021 (dollars in millions). This table excludes any payables or receivables for collateral under repurchase/reverse repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
|  |  |  | Estimated Fair |  | Fair Value Measurement Using:
December 31, 2022: |  | Carrying Value (1) |  | Value |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |
Mortgage loans |  | $ | 6,590 |  |  | $ | 6,109 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,109 |
Policy loans |  | 1,231 |  |  | 1,231 |  |  | — |  |  | 1,231 |  |  | — |
Funds withheld at interest |  | 6,319 |  |  | 5,884 |  |  | — |  |  | — |  |  | 5,884 |
Limited partnerships – cost method |  | 49 |  |  | 52 |  |  | — |  |  | — |  |  | 52 |
Cash and cash equivalents |  | 1,392 |  |  | 1,392 |  |  | 1,392 |  |  | — |  |  | — |
Short-term investments |  | 33 |  |  | 33 |  |  | 33 |  |  | — |  |  | — |
Other invested assets |  | 947 |  |  | 758 |  |  | 4 |  |  | 65 |  |  | 689 |
Accrued investment income |  | 630 |  |  | 630 |  |  | — |  |  | 630 |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities |  | $ | 23,493 |  |  | $ | 23,065 |  |  | $ | — |  |  | $ | — |  |  | $ | 23,065 |
Other liabilities – funds withheld at interest |  | 1,596 |  |  | 1,321 |  |  | — |  |  | — |  |  | 1,321 |
Long-term debt |  | 3,961 |  |  | 3,670 |  |  | — |  |  | — |  |  | 3,670 |
December 31, 2021: |  |  |  |  |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |  |  |
Mortgage loans |  | $ | 6,283 |  |  | $ | 6,580 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,580 |
Policy loans |  | 1,234 |  |  | 1,234 |  |  | — |  |  | 1,234 |  |  | — |
Funds withheld at interest |  | 6,747 |  |  | 7,075 |  |  | — |  |  | — |  |  | 7,075 |
Limited partnerships – cost method |  | 63 |  |  | 81 |  |  | — |  |  | — |  |  | 81 |
Cash and cash equivalents |  | 1,810 |  |  | 1,810 |  |  | 1,810 |  |  | — |  |  | — |
Short-term investments |  | 23 |  |  | 23 |  |  | 23 |  |  | — |  |  | — |
Other invested assets |  | 847 |  |  | 826 |  |  | 6 |  |  | 70 |  |  | 750 |
Accrued investment income |  | 533 |  |  | 533 |  |  | — |  |  | 533 |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |
Interest-sensitive contract liabilities |  | $ | 18,625 |  |  | $ | 19,540 |  |  | $ | — |  |  | $ | — |  |  | $ | 19,540 |
Other liabilities – funds withheld at interest |  | 1,658 |  |  | 1,657 |  |  | — |  |  | — |  |  | 1,657 |
Long-term debt |  | 3,667 |  |  | 3,886 |  |  | — |  |  | — |  |  | 3,886 |
Collateral finance and securitization notes |  | 180 |  |  | 153 |  |  | — |  |  | — |  |  | 153 |
(1)Carrying values presented herein may differ from those in the Company’s consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.

X
- Definition Carrying amounts and estimated fair value of financial instruments. + References No definition available. + Details
Name: | rga_FinancialInstrumentsCarryingAmountsAndEstimatedFairValueTableTextBlock
Namespace Prefix: | rga_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration